CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company ...

Partnership leverages AI-powered genome design to optimize AAV constructs, accelerate lead candidate selection, and improve drug substance manufacturability for rare and ultra-rare neuromuscular ...

Flu could quickly be diagnosed at home by simply chewing gum, suggests a new study. With flu season fast approaching, scientists say the taste-based influenza test would remove the need for taking ...

Australia’s largest private health insurer expands its AUD $10M psychotherapy program to cover psilocybin for Treatment-Resistant Depression, building on earlier MDMA coverage for PTSD Medibank, ...

Marker Therapeutics initiated Phase 1 RAPID study to investigate Multi-Antigen Recognizing (MAR) T cells as an Off-the-Shelf (OTS) product to accelerate time to treatment OTS product was well ...

Abstract: In this study, a Planar Inverted-F Antenna (PIFA) array is designed as a RF bio-sensor in the ISM (Industrial Scientific Medical) band for blood glucose monitoring. The proposed antenna ...

The UK is investing more than $673 million in sensors to help protect its satellites that are vulnerable to attack from lasers. The UK Armed Forces project, announced Friday, is designed to protect ...